Jonathan E. Rosenberg, MD
Jonathan E. Rosenberg, M.D. joined the Memorial Sloan-Kettering Cancer Institute in 2012 as an Associate Physician and the Section Head for non-prostate genitourinary malignancies. He is focusing on correlating novel genomic findings with clinical outcomes in bladder cancer, as well as developing and testing novel treatment strategies in bladder cancer. Dr. Rosenberg is also a member of the Cancer and Leukemia Group B Genitourinary Oncology Core Committee, serves on the NCI Bladder Cancer Task Force, and leads the Cancer and Leukemia Group B Bladder Cancer Sub-Committee.
Prior to coming to Memorial, Dr. Rosenberg was the Clinical Director of the Lank Center for Genitourinary Oncology and the Director of the Dana-Farber/Brigham and Women’s Hospital Bladder Cancer Center at the Dana-Farber Cancer Institute. He was also an Assistant Professor at Harvard Medical School.
Dr. Rosenberg’s awards and honors include a DOD Physician Research Training Award and a 2009 Dunkin Donuts Rising Star Award. He has led many multi-institutional trials in bladder and prostate cancer. He is a member of the American Society of Clinical Oncology and an Editorial Board Member of the Journal of Clinical Oncology.
Dr. Rosenberg received his BS from Duke University and his MD from Harvard Medical School. He completed an internship and residency in Internal Medicine at New York Presbyterian Hospital-Cornell and completed a clinical fellowship in Hematology/Oncology at the University of California Medical Center where he had been on the faculty for 5 years before joining the Dana Farber Cancer Institute.